Live News EQUITY FLASH L impact Oct 30, 2026, 01:36 PM UTC Immunome Desmoid Tumor Drug Application Validated in Europe Immunome said the European Medicines Agency validated its drug application for desmoid tumors. IMNM SquawkNews Desk